Explore
Trendline
Judge Delays Approval of Elon Musk's $1.5M Settlement with SEC Over Twitter Disclosures
Judge Delays Approval of Elon Musk's $1.5M Settlement with SEC Over Twitter Disclosures
Read More
Trendline
Super Micro Faces Securities Class Action Over Export Control Violations
Super Micro Faces Securities Class Action Over Export Control Violations
Read More
Trendline
Trader Joe's Wins Partial Victory in 401(k) Forfeiture Case, Trial Continues
Trader Joe's Wins Partial Victory in 401(k) Forfeiture Case, Trial Continues
Read More
Trendline
Baker McKenzie Leads Consumer M Deal Rankings in Q1 2026
Baker McKenzie Leads Consumer M Deal Rankings in Q1 2026
Read More
Trendline
Inspire Brands Moves Forward with IPO Plans Amid Economic Challenges
Inspire Brands Moves Forward with IPO Plans Amid Economic Challenges
Read More
Trendline
Bel Group Acquires Brainiac Brand to Enhance Brain Health Snack Offerings
Bel Group Acquires Brainiac Brand to Enhance Brain Health Snack Offerings
Read More
Trendline
AMC Global Media Reports $4 Million Restructuring Charge Amid Streaming Revenue Growth
AMC Global Media Reports $4 Million Restructuring Charge Amid Streaming Revenue Growth
Read More
Trendline
Sunoco's Earnings Triple in Q1 2026 Amid Aggressive Acquisition Strategy
Sunoco's Earnings Triple in Q1 2026 Amid Aggressive Acquisition Strategy
Read More
Trendline
Installed Building Products Reports Q1 2026 Financial Results and Announces Dividend Increase
Installed Building Products Reports Q1 2026 Financial Results and Announces Dividend Increase
Read More
Trendline
Cooley LLP Appoints Mona Dajani to Lead Infrastructure and Energy Initiatives
Cooley LLP Appoints Mona Dajani to Lead Infrastructure and Energy Initiatives
Read More
Trendline
Kenvue Reports 8.4% Increase in Beauty Sales, Reaching $1 Billion in Q1 2026
Kenvue Reports 8.4% Increase in Beauty Sales, Reaching $1 Billion in Q1 2026
Read More
Trendline
Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding into U.S. Market
Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding into U.S. Market
Read More